Author: Michael Jannicelli
AKKERMANSIA MUCINIPHILA
Posted by Michael Jannicelli | Oct 9, 2023 | Uncategorized | 0 |
I searched the site but have not seen any discussion around this probiotic specific to CD. Does...
Read MoreProbiotic: AKKERMANSIA MUCINIPHILA
Posted by Michael Jannicelli | Oct 9, 2023 | Uncategorized | 0 |
I searched the site but have not seen any discussion around this probiotic specific to CD. Does...
Read MoreTravel 6 days after fistula drainage surgery
Posted by Michael Jannicelli | Oct 9, 2023 | Uncategorized | 0 |
Hi folks. I’ve had a hell of a time with ischiorectal & peri anal abscesses. Last...
Read MorePsychedelics improve mental health, cognition in special ops veterans
Posted by Michael Jannicelli | Oct 8, 2023 | Uncategorized | 0 |
One treatment each of two psychedelic drugs lowered depression and anxiety and improved cognitive...
Read MoreRecent Posts
- Eli Lilly’s Omvoh (mirikizumab) beats J&J’s Stelara in head-to-head study
- Current research opportunity on IBD and LGB people in the UK
- A potential non-invasive stool test and novel therapy for endometriosis
- Early exposure to antibiotics decreases risk of developing crohn’s disease.
- Faulty ‘fight or flight’ response drives deadly C. difficile infections, research reveals
Recent Comments
No comments to show.